|
Volumn 89, Issue 1-2, 1998, Pages 15-22
|
Correlations between pulmonary pharma-cokinetics and pharmacodynamics allow the use of ceftazidime at a dose of 1 g once a day to be hypothesised in the treatment of bacterial exacerbations of chronic obstructive pulmonary disease with moderate functional damage;Le correlazioni esistenti tra farmacocinetica polmonare e farmacodinamica permettono di ipotizzare l'utilizzo del ceftazidime alla dose di 1 g una sola volta al giorno nel trattamento delle riacutizzazioni batteriche della broncopneumopatia cronica ostruttiva con danno funzionale moderato
a a a a a a
a
NONE
(Italy)
|
Author keywords
Administration and dosage; Ceftazidime; Therapeutic use Chronic obstructive pulmonary disease Ceftazidime
|
Indexed keywords
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
CEFTAZIDIME;
CEPHALOSPORIN DERIVATIVE;
COTRIMOXAZOLE;
ERYTHROMYCIN;
MACROLIDE;
TETRACYCLINE DERIVATIVE;
ANTIBIOTIC THERAPY;
ARTICLE;
BACTERICIDAL ACTIVITY;
BACTERIOSTASIS;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL ARTICLE;
ESCHERICHIA COLI;
FORCED EXPIRATORY VOLUME;
HAEMOPHILUS INFLUENZAE;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MINIMUM INHIBITORY CONCENTRATION;
MORAXELLA CATARRHALIS;
OUTPATIENT;
SPUTUM ANALYSIS;
STREPTOCOCCUS PNEUMONIAE;
BACTERIAL INFECTIONS;
BRONCHOPNEUMONIA;
CEFTAZIDIME;
CEPHALOSPORINS;
CHRONIC DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
LUNG DISEASES, OBSTRUCTIVE;
MALE;
RECURRENCE;
|
EID: 0031960752
PISSN: 00264806
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (22)
|